Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Location: Fort Worth TX, Arlington TX, Willow Park TX, Dallas TX,
Sponsor: Amgen
Sex: All
Age: 50+
Code: NCT07614776
Phase 3, Recruiting
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
for
Multiple Myeloma
Location: Fort Worth TX, Nashville TN, Chattanooga TN,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05714839
Phase 1, Phase 2, Recruiting
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
for
HIV Infections
Location: Forth Worth TX, Dallas TX, Hidden Valley Lake CA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07682961
Phase 3, Recruiting
A Study of Brenipatide in Adult Participants With Schizophrenia
for
Schizophrenia
Location: Fort Worth TX, DeSoto TX, Little Rock AR, St Louis MO,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 55
Code: NCT07410507
Phase 2, Recruiting
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
for
Advanced Melanoma
Location: Los Angeles CA, Sugar Land TX, Hot Springs AR,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18+
Code: NCT06697301
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
for
Heart Failure
Location: Fort Worth TX, Irving TX, Dallas TX, McKinney TX,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06935370
Phase 3, Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
for
Heart Failure
Location: Fort Worth TX, Dallas TX, McKinney TX, Longview TX,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06424288
Phase 3, Recruiting
Trifecta-Heart cfDNA-MMDx Study
for
Heart Transplant Rejection
Location: Dallas TX, Little Rock AR, Tampa FL, Salt Lake City UT,
Sponsor: University of Alberta
Sex: All
Age: 0+
Code: NCT04707872
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Fort Worth TX, Oklahoma City OK, Nashville TN,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06703073
Phase 2, Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Fort Worth TX, Oklahoma City OK, Denver CO,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701682
Phase 2, Recruiting
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
for
Ovarian Cancer
Location: Fort Worth TX, Orlando FL, Fountain Valley CA,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Sex: Female
Age: 18+
Code: NCT07546500
Phase 3, Recruiting
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
for
Cancer
Location: Fort Worth TX, Dallas TX, Waxahachie TX, Plano TX,
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT05371756
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Fort Worth TX, Oklahoma City OK, Denver CO,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701656
Phase 2, Recruiting
Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome
for
Hepatorenal Syndrome, Acute Kidney Injury
Location: Fort Worth TX, Nashville TN, Atlanta GA, Rochester MN,
Sponsor: River 2 Renal Corp.
Sex: All
Age: 18+
Code: NCT05875948
Phase 2, Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Fort Worth TX, Oklahoma City OK, Denver CO,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701669
Phase 2, Recruiting
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
for
Large B-cell Lymphoma, Lymphoma, B-Cell,
Location: Fort Worth TX, Austin TX, San Antonio TX, Houston TX,
Sponsor: Lyell Immunopharma, Inc.
Sex: All
Age: 18+
Code: NCT07188558
Phase 3, Recruiting
Telescope Exchange Study
for
Age-related Macular Degeneration
Location: Fort Worth TX, Springfield MO, Memphis TN,
Sponsor: VisionCare, Inc.
Sex: All
Age: 65+
Code: NCT03011554
Recruiting
A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)
for
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
Location: Fort Worth TX, Orlando FL, Fountain Valley CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07743164
Phase 3, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: Fort Worth TX, Flower Mound TX, Dallas TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06966700
Phase 3, Recruiting
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
for
Crohn's Disease, Ulcerative Colitis
Location: Fort Worth TX, Southlake TX, Mansfield TX, Garland TX,